RxDoctor Payments Data

Gerri Rine

Nurse Practitioner · Tiffin, OHNPI 1578561379

Payments from drug & device makers

$535in general payments, 2019–2025

Across 28 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$112
  • Novo Nordisk$78
  • AstraZeneca$76
  • Phathom Pharmaceuticals, Inc.$48
  • AbbVie$31
  • Amgen$30
  • plus $159 from 8 others

What the payments were for

  • Food & beverage$44182%
  • Education$9418%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$535 in reported general payments places this provider in the 75th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$90,826
Medicare patients
183
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$65,857
TrulicityDulaglutide44$49,375
JardianceEmpagliflozin53$41,628
FarxigaDapagliflozin Propanediol44$29,256
JanuviaSitagliptin Phosphate25$27,634
EliquisApixaban27$26,415
Tresiba Flextouch U-200Insulin Degludec24$14,437
Breo ElliptaFluticasone/Vilanterol22$10,853
Tresiba Flextouch U-100Insulin Degludec15$10,155
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$7,734
Atorvastatin Calcium310$2,296
SynthroidLevothyroxine Sodium30$1,852
Gabapentin123$1,710
Pantoprazole Sodium115$1,651
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$1,619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$78$65,85769 claims
Lilly USA, LLCTrulicity$29$49,37544 claims
Boehringer IngelheimJardiance$14$41,62853 claims
AstraZenecaFarxiga$76$29,25644 claims
PfizerEliquis$22$26,41527 claims
AbbVieSynthroid$31$1,85230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Tiffin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →